AzTrials
AzTrials

AnesthesiaEPOCNCT06225037

EEG-guided Propofol Sedation Versus Standard Care for Oesophagogastroduodenoscopy and Colonoscopy in Children

A study testing Sedline EEG monitoring and Sedline EEG with output concealed in people with Anesthesia and Anesthesia; Adverse Effect, run by KK Women's and Children's Hospital at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare electroencephalogram (EEG) guided propofol sedation versus standard care in paediatric patients aged 6-16 undergoing oesophagogastroduodenoscopy and colonoscopy. Read more about this study

Who is it for?
Ages 6 to 16 years
What is being tested?
Sedline EEG monitoring and Sedline EEG with output concealed
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSingapore
Study dates
15 Dec 2023to 25 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Paediatric patients aged 6-16 who are undergoing oesophagogastroduodenoscopy and colonoscopy in KKH under propofol sedation
  • Parent/guardian must consent to participation in the study and patient must assent to participation in the study

Who cannot join

  • Patients with neurological diseases including seizure disorders
  • Patients with developmental delay or genetic syndromes
  • Patients with craniofacial deformities where it is not possible to place the EEG sensors
  • Patients with severe eczema or skin allergy or atopy
  • Patients who require sedative premedication or who require inhalational induction prior to initiation of propofol sedation

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • KK Women and Children's Hospital

    Singapore, 229899

Other trials in Singapore

About this study

Official title: EEG-guided Propofol Sedation Versus Standard Care for Oesophagogastroduodenoscopy and Colonoscopy in Children: A Randomised Controlled Trial to Improve Sedation Safety and Experience

The goal of this clinical trial is to compare electroencephalogram (EEG) guided propofol sedation versus standard care in paediatric patients aged 6-16 undergoing oesophagogastroduodenoscopy and colonoscopy. The main questions it aims to answer are whether EEG guided propofol sedation will result in:

  • faster wake up time
  • reduced time to discharge
  • reduced cumulative propofol dosage
  • lower incidence of intraoperative adverse events
  • no difference in intraoperative undesirable movement
  • lower incidence and severity of emergence delirium
  • lower intraoperative depth of sedation Participants will wear an EEG sensor (Sedline) prior to undergoing propofol sedation until they wake up post procedure.
Read the detailed description

BACKGROUND AND RATIONALE Oesophagogastroduodenoscopy (OGD) and colonoscopy in children are often performed under deep sedation with propofol. Titration of propofol dosage is based solely on cardiorespiratory parameters obtained from standard ASA monitoring. However, this method of propofol titration does not allow visualisation of the patients' brain response and often leads to under- or over-sedation. Under-sedation can lead to undesirable intra-operative movement and potential awareness, while over-sedation is associated with complications such as apnea, hypoxaemia, hypotension, prolonged time to awakening and delay in PACU discharge.(1,2)

Patients are often over-sedated during propofol anaesthesia. A study in adults undergoing colonoscopy using electroencephalography (EEG) monitoring showed that although providers planned for moderate-to-deep sedation, retrospective review of the EEG revealed that many patients were under general anesthesia, often with burst suppression (3) EEG burst suppression has been linked to postoperative deliriumin the elderly (4), and anesthesia titration to minimize burst suppression may decrease the incidence of postoperative delirium. Likewise, over-sedation and EEG isoelectric events are common in children undergoing propofol anesthesia with dosing based solely on population pharmacokinetics and patient haemodynamics. (5)

It was recently proposed that EEG monitoring and guidance during anaesthesia and sedation in children allows direct visualisation of each patient's brain response and complements current standard monitoring to enhance patient safety and experience.(2) EEG-guidance has been shown to reduce sevoflurane requirements in children undergoing general anaesthesia. (9) In particular, the EEG spectrogram, also called density spectral array (DSA), allows easy visualisation of the interactions between brain response, hemodynamic response, and changing procedural stimulation in real time, thus facilitating more precise and nuanced titration of anaesthetic agents. (2)

Processed EEG (pEEG) such as the bispectral index (BIS), Narcotrend index (NI) and patient state index (PSI) are dimensionless numbers derived from the EEG using manufacturers' algorithms to quantify anaesthetic depth (6). However, given the lack of clarity on how different pEEG numbers are computed and how they relate to fundamental neurophysiological properties of the developing brain, it is important to interpret the pEEG number in relation to the raw EEG waveform and spectrogram.

Only two small studies have compared EEG-guided propofol anaesthesia with standard care in children, both using the Narcotrend Index (NI). NI-guidance was shown to result in slightly faster recovery and lower drug consumption.(7)(8). To date, no study has utilised the spectrogram together with the pEEG number to guide anaesthesia. The investigators aim to compare EEG-guidance using Sedline EEG and spectrogram, in addition to the PSI, with standard care in children undergoing propofol TIVA for OGD and colonoscopy. Better visualisation of the brain response using the spectrogram may lead to more precise titration of propofol doses, lower propofol consumption and greater reduction in wake up time.

List of references:

  1. Patino M, Glynn S, Soberano M, Putnam P, Hossain MM, Hoffmann C, Samuels P, Kibelbek MJ, Gunter J. Comparison of different anesthesia techniques during esophagogastroduedenoscopy in children: a randomized trial. Paediatr Anaesth. 2015;25:1013-1019. Cited: in: : PMID: 26184697.
  2. Bong CL, Balanza GA, Khoo CE-H, Tan JS-K, Desel T, Purdon PL. A Narrative Review Illustrating the Clinical Utility of Electroencephalogram-Guided Anesthesia Care in Children. Anesth Analg [Internet]. 2022; doi: 10.1213/ANE.0000000000006267. Cited: in: : PMID: 36729437.
  3. Bloom J, Wyler D, Torjman MC, Trinh T, Li L, Mehta A, Fitchett E, Kastenberg D, Mahla M, Romo V. High Incidence of Burst Suppression during Propofol Sedation for Outpatient Colonoscopy: Lessons Learned from Neuromonitoring. Anesthesiol Res Pract. 2020;2020:7246570. Cited: in: : PMID: 32636880.
  4. Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016;122:234-242. Cited: in: : PMID: 26418126.
  5. Yuan I, Landis WP, Topjian AA, Abend NS, Lang S-S, Huh JW, Kirschen MP, Mensinger JL, Zhang B, Kurth CD. Prevalence of Isoelectric Electroencephalography Events in Infants and Young Children Undergoing General Anesthesia. Anesth Analg. 2020;130:462-471. Cited: in: : PMID: 31107263.
  6. Soehle M, Kuech M, Grube M, Wirz S, Kreuer S, Hoeft A, Bruhn J, Ellerkmann RK. Patient state index vs bispectral index as measures of the electroencephalographic effects of propofol. Br J Anaesth. 2010;105:172-178. Cited: in: : PMID: 20587537.
  7. Weber F, Walhout LC, Escher JC. The impact of NarcotrendTM EEG-guided propofol administration on the speed of recovery from pediatric procedural sedation-A randomized controlled trial. Paediatr Anaesth. 2018;28:443-449. Cited: in: : PMID: 29575232.
  8. Weber F, Pohl F, Hollnberger H, Taeger K. Impact of the Narcotrend Index on propofol consumption and emergence times during total intravenous anaesthesia with propofol and remifentanil in children: a clinical utility study. Eur J Anaesthesiol. 2005;22:741-747. Cited: in: : PMID: 16211731.
  9. Long MHY, Lim EHL, Balanza GA, Allen JC Jr, Purdon PL, Bong CL. Sevoflurane requirements during electroencephalogram (EEG)-guided vs standard anesthesia Care in Children: A randomized controlled trial. J Clin Anesth. 2022;81:110913. Cited: in: : PMID: 35772250.

HYPOTHESIS AND OBJECTIVES The primary hypothesis is that in children aged 6-16, personalised EEG-guided anaesthesia care using the Sedline, (based on the raw EEG, density spectral array, in addition to the patient state index (PSI)), will result in faster wake up (defined as time from end of procedure to time of first eye opening) after propofol sedation for OGD and colonoscopy by 8 minutes.

Our secondary hypotheses are that in children aged 6 to 16, personalised EEG-guided anaesthesia care using the Masimo Sedline, (based on the unprocessed EEG, density spectral array, in addition to the patient state index (PSI)) leads to:

  1. A reduction in time to discharge from PACU (defined as time from PACU arrival to time of meeting PACU discharge criteria) by 15 minutes
  2. A reduction of propofol dosage (cumulative/kg/time) by 10%
  3. Lower incidence of intraoperative adverse events: apnea, hypoventilation requiring bag mask ventilation, laryngospasm, hypotension.
  4. No difference in intraoperative undesirable movement
  5. Lower Incidence and severity of emergence delirium as measured by the Paediatric Anaesthesia Emergence Delirium (PAED) scale
  6. Lower intra-operative depth of sedation as measured by incidence and duration of burst suppression, intra-operative spectral edge frequency; alpha power and frequency; slow power and frequency.

Our primary aim is to determine if personalised EEG-guided anaesthesia care using the Sedline reduces the time to wake up after propofol sedation for oesophagogastroduodenoscopy (OGD) and colonoscopy.

Our secondary aims are to determine if personalised EEG-guided anaesthesia care reduces

  1. Time to discharge from PACU
  2. Total propofol dose used (cumulative mg/kg/min)
  3. Incidence of intraoperative adverse events: apnea, hypoventilation requiring bag mask ventilation, laryngospasm, hypotension
  4. Incidence of intra-operative undesirable movement
  5. Incidence and severity of emergence delirium
  6. Intra-operative depth of sedation

Inclusion Criteria

Subjects must meet all of the inclusion criteria to participate in this study. Inclusion Criteria:

  1. Paediatric patients aged 6-16 who are undergoing oesophagogastroduodenoscopy and colonoscopy in KKH under propofol sedation
  2. Parent/guardian must consent to participation in the study and patient must assent to participation in the study

Exclusion Criteria

Subjects meeting any of the exclusion criteria at baseline will be excluded from participation in the study. Exclusion Criteria:

  1. Patients with neurological diseases including seizure disorders
  2. Patients with developmental delay or genetic syndromes
  3. Patients with craniofacial deformities where it is not possible to place the EEG sensors
  4. Patients with severe eczema or skin allergy or atopy
  5. Patients who require sedative premedication or who require inhalational induction prior to initiation of propofol sedation

STUDY DESIGN AND PROCEDURES/METHODOLOGY This is a single centre randomized controlled study of 50 children aged 6-16 years of age undergoing oesophagogastroduodenoscopy or colonoscopy under intravenous anaesthesia with propofol.

Following institutional ethics approval and written informed consent, children aged 6 to 16 receiving propofol sedation for colonoscopy lasting will be randomised in a 1:1 ratio to either:

Group 1: EEG Monitoring: EEG sensor placed with the EEG monitored. Propofol titrated according to the raw EEG and spectrogram, aiming to maintain sedation (alpha oscillations +/- slow oscillations) and preventing burst suppression, keeping the PSI greater than 25 where possible.

Group 2: Standard Care: EEG sensor placed with the output concealed. The anaesthesia team is blinded to the EEG data. Propofol is titrated according to routine standard care.

The EEG sensor will be placed over the forehead prior to induction of anaesthesia, and removed once the patient is awake at the conclusion of general anaesthesia. Routine monitors including ECG, pulse oximetry and non-invasive blood pressure will be placed and the patients managed according to standard care.

The pharynx will be tropicalized with 10% Xylocaine spray prior to insertion of the endoscope.

Fentanyl 0.5 mcg/kg and lignocaine 0.5mg/kg will be given prior to induction.

Propofol target controlled infusion (TCI) - Paedfusor model, will be used. The induction dose will be Cp 4.0mcg/ml and then titrated to patient response with (group 1) or without (group 2) EEG guidance.

Intra-operatively, the details of the anaesthetic, including the duration of sedation, TCI dosage at different pre-specified time points and cumulative propofol dosage, will be recorded. EEG characteristics during insertion of scope, maintenance, removal of scope and emergence will be noted. Any undesirable intraoperative patient movements, adverse events including apnea, hypoventilation requiring bag mask ventilation, laryngospasm, hypotension will also be recorded.

In the PACU, the time to wake up, time to PACU discharge, and the incidence and severity of emergence delirium will be recorded. The EEG information will be downloaded and anonymised for analysis. The incidence and duration of burst suppression, spectral edge frequency; alpha power and frequency; slow power and frequency will be recorded.

The investigators will compare the:

  1. Time to wake up (defined as time from end of procedure to time of first eye opening)
  2. Time to discharge from PACU (defined as time from PACU arrival to time of meeting PACU discharge criteria)
  3. Total propofol dose used (cumulative mg/kg/min)
  4. Incidence of intraoperative adverse events: apnea, hypoventilation requiring bag mask ventilation, laryngospasm, hypotension
  5. Incidence of intra-operative undesirable movement
  6. Incidence and severity of emergence delirium (as measured by the Paediatric Anaesthesia Emergence Delirium (PAED) scale)
  7. Intra-operative depth of sedation (as measured by incidence and duration of burst suppression, intra-operative spectral edge frequency; alpha power and frequency; slow power and frequency)
Being tested
Sedline EEG monitoring, Sedline EEG with output concealed
Keywords
EEG-guided sedation
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sedline EEG monitoringDevice

    Propofol titrated according to the raw EEG and spectrogram, aiming to maintain sedation (alpha oscillations +/- slow oscillations) and preventing burst suppression, keeping the PSI greater than 25 where possible.

  • Sedline EEG with output concealedDevice

    Clinician will be blinded to the sedline output but data will be collected for analysis (Sedline output will only be analysed at data analysis)

Study groups in NCT06225037
Study groupRoleWhat they receive
Group 1: EEG MonitoringExperimentalEEG sensor placed with the EEG monitored.
Receives: Device: Sedline EEG monitoring
Group 2: Standard CareActive comparatorEEG sensor placed with the output concealed.
Receives: Device: Sedline EEG with output concealed

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to wake up

    Our primary hypothesis is that in children aged 6-16, personalised EEG-guided anaesthesia care using the Sedline, (based on the raw EEG, density spectral array, in addition to the patient state index (PSI)), will result in faster wake up (defined as time from end of procedure to time of first eye opening) after propofol sedation for OGD and colonoscopy by 8 minutes

    Measured: Through study completion, approximately 6 months

Secondary outcomes (6)
  1. Time to discharge

    A reduction in time to discharge from PACU (defined as time from PACU arrival to time of meeting PACU discharge criteria) by 15 minutes

    Measured: Through study completion, approximately 6 months

  2. Propofol dosage

    A reduction of propofol dosage (cumulative/kg/time) by 10%

    Measured: Through study completion, approximately 6 months

  3. Intraoperative adverse events

    Lower incidence of intraoperative adverse events: apnea, hypoventilation requiring bag mask ventilation, laryngospasm, hypotension.

    Measured: Through study completion, approximately 6 months

  4. Undesirable movement

    No difference in intraoperative undesirable movement

    Measured: Through study completion, approximately 6 months

  5. Emergence delirium

    Lower Incidence and severity of emergence delirium as measured by the "Paediatric Anaesthesia Emergence Delirium scale" (PAED scale), a scale from 0-20 where higher scores indicate a worse outcome.

    Measured: Through study completion, approximately 6 months

  6. Depth of sedation

    Lower intra-operative depth of sedation as measured by incidence and duration of burst suppression, intra-operative spectral edge frequency; alpha power and frequency; slow power and frequency.

    Measured: Through study completion, approximately 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2024
  2. Study start15 Dec 2023
  3. Primary completion25 Oct 2024
  4. Study completion25 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06225037
Sponsor's protocol ID
2023/2337
Acronym
EPOC
Status last verified
Feb 2025
First submitted
19 Dec 2023
Last updated
18 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Patino M, Glynn S, Soberano M, Putnam P, Hossain MM, Hoffmann C, Samuels P, Kibelbek MJ, Gunter J. Comparison of different anesthesia techniques during esophagogastroduedenoscopy in children: a randomized trial. Paediatr Anaesth. 2015 Oct;25(10):1013-9. doi: 10.1111/pan.12717. Epub 2015 Jul 17.

    PubMed 26184697
  • Bong CL, Balanza GA, Khoo CE, Tan JS, Desel T, Purdon PL. A Narrative Review Illustrating the Clinical Utility of Electroencephalogram-Guided Anesthesia Care in Children. Anesth Analg. 2023 Jul 1;137(1):108-123. doi: 10.1213/ANE.0000000000006267. Epub 2023 Jun 16.

    PubMed 36729437
  • Bloom J, Wyler D, Torjman MC, Trinh T, Li L, Mehta A, Fitchett E, Kastenberg D, Mahla M, Romo V. High Incidence of Burst Suppression during Propofol Sedation for Outpatient Colonoscopy: Lessons Learned from Neuromonitoring. Anesthesiol Res Pract. 2020 Jun 19;2020:7246570. doi: 10.1155/2020/7246570. eCollection 2020.

    PubMed 32636880
  • Fritz BA, Kalarickal PL, Maybrier HR, Muench MR, Dearth D, Chen Y, Escallier KE, Ben Abdallah A, Lin N, Avidan MS. Intraoperative Electroencephalogram Suppression Predicts Postoperative Delirium. Anesth Analg. 2016 Jan;122(1):234-42. doi: 10.1213/ANE.0000000000000989.

    PubMed 26418126
  • Yuan I, Landis WP, Topjian AA, Abend NS, Lang SS, Huh JW, Kirschen MP, Mensinger JL, Zhang B, Kurth CD. Prevalence of Isoelectric Electroencephalography Events in Infants and Young Children Undergoing General Anesthesia. Anesth Analg. 2020 Feb;130(2):462-471. doi: 10.1213/ANE.0000000000004221.

    PubMed 31107263
  • Soehle M, Kuech M, Grube M, Wirz S, Kreuer S, Hoeft A, Bruhn J, Ellerkmann RK. Patient state index vs bispectral index as measures of the electroencephalographic effects of propofol. Br J Anaesth. 2010 Aug;105(2):172-8. doi: 10.1093/bja/aeq155. Epub 2010 Jun 29.

    PubMed 20587537
  • Weber F, Walhout LC, Escher JC. The impact of Narcotrend EEG-guided propofol administration on the speed of recovery from pediatric procedural sedation-A randomized controlled trial. Paediatr Anaesth. 2018 May;28(5):443-449. doi: 10.1111/pan.13365. Epub 2018 Mar 25.

    PubMed 29575232
  • Weber F, Pohl F, Hollnberger H, Taeger K. Impact of the Narcotrend Index on propofol consumption and emergence times during total intravenous anaesthesia with propofol and remifentanil in children: a clinical utility study. Eur J Anaesthesiol. 2005 Oct;22(10):741-7. doi: 10.1017/s0265021505001237.

    PubMed 16211731
  • Long MHY, Lim EHL, Balanza GA, Allen JC Jr, Purdon PL, Bong CL. Sevoflurane requirements during electroencephalogram (EEG)-guided vs standard anesthesia Care in Children: A randomized controlled trial. J Clin Anesth. 2022 Oct;81:110913. doi: 10.1016/j.jclinane.2022.110913. Epub 2022 Jun 27.

    PubMed 35772250

Questions about this trial

What is this clinical trial studying?

A study testing Sedline EEG monitoring and Sedline EEG with output concealed in people with Anesthesia and Anesthesia; Adverse Effect, run by KK Women's and Children's Hospital at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to wake up (time frame: Through study completion, approximately 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06225037, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in